[Primary prevention of coronary heart disease with aspirin].

Author: DariusH, KüblerW

Paper Details 
Original Abstract of the Article :
According to meta-analysis and the results of the two studies with the highest power, aspirin is effective in primary prevention of coronary heart disease. These beneficial effects, however, are at least partially out-weight by unwanted effects-such as intense gastrointestinal bleeding and hemorrhag...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00392-005-1309-8

データ提供:米国国立医学図書館(NLM)

Aspirin for Heart Health: A Balancing Act?

The field of [cardiology] is constantly seeking effective strategies for [primary prevention of coronary heart disease]. This research explores the potential role of [aspirin] in this crucial endeavor. The authors conducted a [meta-analysis] of existing studies to evaluate the efficacy and safety of [aspirin] in preventing [coronary heart disease]. Their findings reveal that [aspirin is effective in primary prevention of coronary heart disease]. However, they also highlight the potential [unwanted effects] of [aspirin], including [gastrointestinal bleeding and hemorrhagic stroke]. The researchers emphasize the need for careful consideration of the [risk-benefit profile] of [aspirin] based on individual patient factors.

A Fine Line Between Benefit and Risk

This study underscores the importance of weighing the potential benefits and risks of [aspirin] in the context of [primary prevention of coronary heart disease]. While [aspirin] can effectively reduce the risk of [coronary heart disease], it also carries a risk of [gastrointestinal bleeding and hemorrhagic stroke]. The authors suggest that [aspirin] may be indicated for patients with an annual risk of [coronary heart disease] of [> or =1.5%]. However, for those with a lower risk, the decision should be made on a case-by-case basis after careful consideration of individual factors.

Navigating the Landscape of Heart Health

This research sheds light on the complex interplay of [risk factors] and [treatment options] in the management of [coronary heart disease]. It reminds us that, like navigating a desert, we must carefully choose our path and assess the potential benefits and risks associated with each decision. Consulting with your doctor to discuss your individual [risk factors] and [treatment options] is crucial for making informed choices about your heart health.

Dr. Camel's Conclusion

This study delves into the fascinating world of [aspirin] and its role in preventing [coronary heart disease]. It's like navigating a desert where the path to good health is paved with both benefits and risks. The researchers provide valuable insights into the [risk-benefit profile] of [aspirin], encouraging us to be informed and make thoughtful decisions about our heart health. Just as a camel adapts to the changing desert landscape, we must be flexible and adaptable in our approach to managing [heart disease].

Date :
  1. Date Completed 2006-02-28
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

16258795

DOI: Digital Object Identifier

10.1007/s00392-005-1309-8

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.